Rs7903146 variant of TCF7L2 gene and rs18012824 variant of PPARG2 gene (Pro12Ala) are associated with type 2 diabetes mellitus in Novosibirsk population

Cover Page


 To investigate the association of polymorphisms in TCF7L2 and PPARG2 genes with type 2 diabetes mellitus (T2DM) in Novosibirsk population.
Materials and Methods.
We examined 391 patients with T2DM and 556 individuals with normal glucose metabolism. Allelic identification was performed with TaqMan technique, implementing allele-specific real-time PCR.
 Analysis shows that allelic frequency distribution of rs1801282 variant of PPARG2 gene and rs7903146 variant of TCF7L2 differs significantly between the study and control groups (OR [CI 95%]=1.44 [1.12?1.85], p=0.005 and OR [CI 95%]=1.57 [1.17?2.10], p=0.003, respectively). T2DM patients with T/T genotype of rs7903146 variant of TCF7L2 gene had lower BMI (p=0.02). Observed combination of risk alleles reached 99%. Combined beta-cell dysfunction and insulin resistance genotypes were identified in 56% of tested subjects, isolated insulin resistance ? in 42.2% of subjects, and isolated beta-cell dysfunction ? in 0.8% of subjects.
 Our data shows that carrier state of 12Pro rs1801284 variant of PPARG2 gene and T-allele rs7903146 variant of TCF7L2 gene are associated with T2DM in Novosibirsk population, increasing its risk 1.44 and 1.57 times, respectively. Combination of these polymorphisms was observed in 99% of patients with T2DM.

About the authors

Irina Arkad'evna Bondar'

Novosibirsk State Medical University, Novosibirsk

Author for correspondence.

Russian Federation MD, PhD, Professor, Head of Endocrinology Department

Maksim Leonidovich Filipenko

Institute of Chemical Biology and Fundamental Medicine, Novosibirsk


Russian Federation PhD, Head of Farmacogenomics Laboratory

Olesya Yur'evna Shabel'nikova

Novosibirsk State Regional Hospital, Novosibirsk


Russian Federation MD, PhD, Head of Regional Diabetic Center

Ekaterina Alexandrovna Sokolova

Institute of Chemical Biology and Fundamental Medicine, Novosibirsk


Russian Federation Researcher in Farmacogenomics Laboratory


  1. Robertson RP. The battered β-cell: usual suspects and guilt by association. J Clin Endocrinol Metab. 2011;96(12):3672–3674. doi: 10.1210/jc.2011–2960
  2. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, et al. A Pro12Ala substitution in PPARg2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998;20:84–287.
  3. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, et al. Molecular scanning of the human Peroxisome proliferator activated receptor g (hPPARg) gene in diabetic Caucasians: identification of a Pro12Ala PPARg2 missense mutation. Biochem Biophys Res Commun. 1997;241(2):270–274. doi: 10.1006/bbrc.1997.7798
  4. Kaydashev IP, Rasin AM, Shlykova OA, Gorbas IM, Smirnova IP, Petrushov AV, et al. Frequency of Pro12Ala-polymorphism of the gene PPARγ2 in the Ukrainian population and its possible relation to the development of the metabolic syndrome. Cytology and Genetics. 2007;41(5):298–302. doi: 10.3103/S0095452707050076
  5. Потапов ВА. Поиск генетических маркеров, определяющих предрасположенность к сахарному диабету 2 типа. Автореферат … канд. биол. наук. M; 2010. 24c. [Potapov VA. Poisk geneticheskikh markerov, opredelyayushchikh predraspolozhennost' k sakharnomu diabetu 2 tipa [dissertation]. Moscow; 2010. 24p]
  6. Reynisdottir I, Thorleifsson G, Benediktsson R, Sigurdsson G, Emilsson V, Einarsdottir AS, et al. Localization of a Susceptibility Gene for Type 2 Diabetes to Chromosome 5q34–q35.2. The American Journal of Human Genetics. 2003;73(2):323–335. doi: 10.1086/377139
  7. Grant SFA, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.. Nat Genet. 2006;38(3):320–323. doi: 10.1038/ng1732
  8. Florez JC. The new type 2 diabetes gene TCF7L2. Curr Opin Clin Nutr Metab Care. 2007;10(4):391–396. doi: 10.1097/MCO.0b013e3281e2c9be
  9. Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med. 2007;85(7):777–782. doi: 10.1007/s00109-007-0203-4
  10. Cecil JE, Watt P, Palmer CN, Hetherington M. Energy balance and food intake: the role of PPARgamma gene polymorphisms. Physiol Behav. 2006;88(3):227–233. doi: 10.1016/j.physbeh.2006.05.028
  11. Lyssenko V, Lupi R, Marchetti P, del Guerra S,, Orho-Melander M, Almgren P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest. 2007;117:2155–2163.
  12. Schafer SA, Machicao F, Fritsche A, Haring HU, Kantartzis K. New type 2 diabetes risk genes provide new insights in insulin secretion mechanisms. Diabetes Res Clin Pract. 2011;93(Suppl 1):9–24. doi: 10.1016/S0168-8227(11)70008-0
  13. Farch K, Pilgaard K, Knop FK, Hansen T, Pedersen O, Jorgensen T, et al. Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele. Diabetes Obes Metab. 2013;15(1):91–95. doi: 10.1111/j.1463-1326.2012.01675.x
  14. Le Bacquer O, Kerr-Conte J, Gargani S, Delalleau N, Huyvaert M, Gmyr V, et al. TCF7L2 rs7903146 impairs islet function and morphology in non-diabetic individuals. Diabetologia 2012;55(10):2677–2681. doi: 10.1007/s00125-012-2660-8
  15. Lukacs K, Hosszufalusi N, Dinya E, Bakacs M, Madacsy L, Panczel P. The type 2 diabetes-associated variant inTCF7L2 is associated with latent autoimmune diabetes in adult Europeans and the gene effect is modified by obesity: a meta-analysis and an individual study. Diabetologia. 2012;55(3):689–693. doi: 10.1007/s00125-011-2378-z

Supplementary files

There are no supplementary files to display.



Abstract - 2115

PDF (Russian) - 1079

HTML (Russian) - 1409




Copyright (c) 2013 Bondar' I.A., Filipenko M.L., Shabel'nikova O.Y., Sokolova E.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies